Day 1 | Day 2 | Download Brochure
Tuesday, May 1, 2018
7:30 am Conference Registration and Continental Breakfast
8:30 Welcome Keynote and State of the Neurotechnology Industry
The Neurotechnology Industry Organization and guest speakers provide an annual review of trends and developments in neuropharmaceuticals, neurodevices, and neurodiagnostics.
Panelists: Alison Fenney, Member, Board of Directors, Neurotechnology Industry Organization
Harry Tracy, President, NI Research
James Cavuoto, Editor & Publisher, Neurotech Reports
9:00 Investing in Neurotech Panel
A diverse panel of private, public and strategic investors will discuss their investment strategies. What does it take to get a neurotech company funded? What are the benefits and risks of business models in devices, pharmaceuticals, diagnostics and information technology? What are todays deal terms and valuations? What are the best exit strategies and how is neurotech comparing to other industries?
Moderator: Joshua Pinto, Vice President, Healthcare Investment Banking, Credit Suisse
Panelists: Rahul Ballal, Entrepreneur-in-Residence, Versant Ventures
Laura Tadvalkar, Senior Associate, MP Healthcare Venture Management
Paulina Hill, Principal, Polaris Partners
Jamil Beg, Principal, 5AM Ventures
William Robb, Founding Partner, NovaQuest Capital Management
10:00 Coffee Break with Exhibit Viewing
10:40 Treatments for Alzheimers and Cognitive Disorders
As the population ages, the market for neurodegenerative disorders is exploding. Current treatments stabilize symptoms only for a short period of time. What is on the horizon for symptom improvement and disease modification from drug and device companies? Can earlier or more accurate diagnosis improve outcomes?
Moderator: Michael Gold, Vice President, Development Neurosciences, AbbVie
Panelists: Christopher U. Missling, President and CEO, Anavex Life Sciences
Leen Kawas, President and CEO, M3 Biotechnology
Michael Mullan, CEO, Archer Pharmaceuticals
Casey Lynch, CEO, Cortexyme
Carlos Buesa, CEO, Oryzon
11:40 Developments on the Horizon for Pain and Epilepsy
Drugs and devices with novel mechanisms of action are on the horizon to decrease side effects and improve efficacy in treatment resistant populations for epilepsy and neuropathic pain. Hear from leading companies on their approaches.
Moderator: Robert H. Ring, Founder & President, Auts Consulting and Advisory Solutions
Panelists: Gregory T. Mayes, President, CEO & Founder, Engage Therapeutics, Inc.
Stephen Collins, CEO, Biscayne Neurotherapeutics
Ana Maiques, CEO, NeuroElectrics
Louis Mayaud, CSO, Mensia Technologies
12:40 pm Networking Luncheon
2:00 Internal and External Research and Development
Pharmaceutical and device companies are looking to provide complete solutions that span from prevention to treatment. Functions across the value chain will be kept in house or partnered. This panel of experts will discuss how they approach collaborations with other companies, academic groups, research institutes, and platform companies.
Moderator: Christine de los Reyes, Vice President, Strategic Planning & Business Development, Alopexx Enterprises, LLC
Panelists: Jeff Erb, Senior Director, Strategy and Business Development, Medtronic
Isaac Veinbergs, Head, External Innovation, Sanofi
Eric Schaeffer, Senior Director, Neuroscience Innovation, Johnson & Johnson Innovation
3:00 Refreshment Break with Exhibit Viewing
3:45Targeting Orphan Diseases
Orphan disorders are a hot area of investment due to perceived benefits with regulatory agencies, ready access to patients, and premium pricing. This session will gather companies developing treatments for ALS, lysosomal storage disorders, Huntingtons, and more.
Moderator: Daniel Burch, Global Medical Officer, PPD Biotech
Panelists: Marc Martinell, CEO, Minoryx
Andrew Lim, CEO, Circumvent Pharmaceuticals
Lynn Durham, CEO & Founder, Stalicla
Michael Panzara, Franchise Lead, Neurology, WAVE Life Sciences Ltd.
Pushkal Garg, Chief Medical Officer, Alnylam Pharmaceuticals
David B. Clissold, Director, Hyman, Phelps & McNamara, P.C.
4:45 Strategic Development of Your Product Outside of the US: The Australian Advantage
Tina Soulis, PhD, CEO, Neuroscience Trials Australia
This session will focus on case studies to demonstrate the approval process, regulatory framework, tax advantages, networks and overall capabilities that exist in Australia that could be used as part of a strategic development plan to save time, effort and cost when planning your studies.
5:00 Emerging Company Showcase - Learn More About Our Participants
The third annual Emerging Company Showcase offers the stage to young neurotech companies to pitch their drug, device, diagnostic, or software to an audience of investors, CEOs, and executives in the field.
Moderator: Carla Lema Tome, Advisor, Neurotechnology Industry Organization
Participants: Lowry Curley, CEO, AxoSim, Inc
Dan Rizzuto, CEO, Nia Therapeutics
Shawn Ritchie, CEO and CSO, Med-Life Discoveries LP
Sefi Epel, CEO, Brainmarc
Visar Berisha, Co-Founder, CSO, Aural Analytics
Julie Collens, CEO, Vivid Genomics
Devon Greco, Founder and CEO, Narbis
Kumar Sripathirathan, CEO, DEHA
Steven Prawer, Director, Cofounder, CTO, iBIONICS
Eliav Shaked, Founder & CEO, RetiSpec
6:00 Welcome Reception with Exhibit Viewing
7:00Close of Day
Day 1 | Day 2 | Download Brochure
Wednesday, May 2, 2018
8:00 am Continental Breakfast
8:45Keynote Presentation
Stephanie Fertig, MBA, Director, NINDS Small Business Programs, National Institute of Neurological Disorders and Stroke, National Institutes of Health
9:00 Partnering and Licensing in Neurotech Panel
Big pharma, biotech and medtech need to act to capitalize new innovations that provide solutions to the global demands in healthcare. This insider panel will discuss their areas of interest for in-licensing novel therapeutics, devices and diagnostics and what they look for in a partner.
Moderator: John Reppas, Director, Public Policy, Neurotechnology Industry Organization
Panelists: Murali Gopalakrishnan, Head, Neuroscience Search and Evaluation, AbbVie
Robert Bagdorf, Vice President, Biopharmaceuticals Search and Evaluation, Pfizer
Matt Gunderman, Director, Business Development, Boston Scientific
10:00 Coffee Break with Exhibit Viewing
10:40 Parkinsons and Other Movement Disorders
Current treatments for movement disorders can improve functioning, but suffer from side effects and off period, especially as the disease progresses. A number of novel pipeline pharmaceuticals and devices seek to address these issues. This session will explore how disease modifying treatments alter the course of movement disorders, and how companion diagnostics can be leveraged to provide the most optimal outcomes for patients.
Moderator: Julie G Pilitsis, Chair Dept of Neuroscience & Experimental Therapeutics, Professor of Neurosurgery, Albany Medical College
Panelists: Ralph Kern, COO and CMO, BrainStorm Therapeutics
Randall W. Moreadith, CEO, Serina Therapeutics
Michael Almstetter, CEO, Origenis
Nader Yaghoubi, President and CEO, PathMaker Neurosystems Inc.
Jim DeMesa, CEO, Emerald Health Pharmaceuticals
11:40 Next-Generation Psychiatry
Schizophrenia, anxiety, depression, addiction, ADHD and other psychiatric illnesses represent a large portion of the neurotech market. Development of promising next-generation treatments is challenging. Novel devices and diagnostics are poised to change the treatment landscape. This session will gather the most innovative treatments for mental health disorders.
Moderator: Manuel Lopez-Figueroa, Venture Partner, Bay City Capital
Panelists: Remy Luthringer, CEO, Minerva Neurosciences
Stephen Brannan, CMO, Karuna Pharmaceuticals
Atul Mahableshwarkar, Vice President, Clinical Development, BlackThorn Therapeutics
Michael J. Detke, CMO, Embera Therapeutics
Eric J. Messika, President and CEO, Coronis Neurosciences Ltd.
12:40 pm Networking Luncheon
2:00 Frontiers in Neurotechnology
In this session, we will hear from companies on the cutting edge. Novel neurostimulation devices are being developed for new markets. Closed loop systems create the promise of reduced side effects and more targeted treatment. New technology is yielding benefits in delivery of therapeutics to brain. This session will preview next generation products and companies in neurotechnology.
Moderator: Daniel OConnell, Founding member & Managing Partner, NeuroVentures; President and Chief Executive Officer, Acumen Pharmaceuticals, Inc.
Go here to read the rest:
- Systems-Based Neurotechnology for Emerging Therapies (SUBNETS) - December 8th, 2016 [December 8th, 2016]
- Backing British innovation: Royal Academy of Engineering launches ... - Elite Business Magazine - February 13th, 2017 [February 13th, 2017]
- Global Fingerprint Biometrics in the VAR Market 2016 Fulcrum Biometrics, Neurotechnology, 360 Biometrics ... - Albanian Times - February 16th, 2017 [February 16th, 2017]
- Israel and Indiana: Why You're Getting an Invitation to the Holy Land ... - 93.1 WIBC Indianapolis - February 22nd, 2017 [February 22nd, 2017]
- 5th Annual Big Idea Competition Nets Three Winners Colorado ... - Colorado College News - February 23rd, 2017 [February 23rd, 2017]
- 3Q: US Patent Office's Ruling on CRISPR - Bioscience Technology - February 24th, 2017 [February 24th, 2017]
- 7 reasons you must attend WIRED Health 2017 - Wired.co.uk - February 24th, 2017 [February 24th, 2017]
- Edward Boyden - Big Think - February 25th, 2017 [February 25th, 2017]
- What Health Care Can Learn from Wal-Mart - Wall Street Journal (subscription) (blog) - March 4th, 2017 [March 4th, 2017]
- A report released today by RBC Capital Markets about Stryker Corporation (NYSE:SYK) ups the target price to $135.00 - Breaking Finance News - March 4th, 2017 [March 4th, 2017]
- Paralysis patients achieve fastest typing yet with new brain-computer interface - The Brown Daily Herald - March 7th, 2017 [March 7th, 2017]
- How 'brain wearables' can address 21st century needs - IoT Tech News - March 7th, 2017 [March 7th, 2017]
- Stryker's AVAflex Vertebral Balloon System Receives FDA 510(k ... - OrthoSpineNews - March 8th, 2017 [March 8th, 2017]
- Stryker's Spine Division To Feature Novel 3D-Printed Spinal Implants at AAOS Conference - OrthoSpineNews - March 9th, 2017 [March 9th, 2017]
- Stryker's Spine division to exhibit key technologies at AAOS 2017 - Yahoo Finance - March 9th, 2017 [March 9th, 2017]
- Stryker Corporation named one of Fortune Magazine's 100 Best Companies to Work For for seventh consecutive year - Yahoo Finance - March 9th, 2017 [March 9th, 2017]
- How to ensure future brain technologies will help and not harm society - USAPP American Politics and Policy (blog) - March 10th, 2017 [March 10th, 2017]
- Preview: MedX Future of Healthcare conference - The Mancunion - March 11th, 2017 [March 11th, 2017]
- Stryker's Spine division to exhibit key technologies at AAOS 2017 - OrthoSpineNews - March 11th, 2017 [March 11th, 2017]
- Elon Musk Wants to Merge Man and MachineHere's What He'll ... - Observer - April 8th, 2017 [April 8th, 2017]
- Synchron Inc. Secures $10 Million in Series A Financing Round - PR Newswire (press release) - April 8th, 2017 [April 8th, 2017]
- How Neurotechnology Is Helping The San Francisco Giants Train Better - PSFK (subscription) - April 8th, 2017 [April 8th, 2017]
- Positive Media Coverage Very Likely to Affect Stryker (SYK) Share Price - Chaffey Breeze - June 6th, 2017 [June 6th, 2017]
- Shoosmiths advises PD Neurotechnology on 1.34m investment - Scottish Legal News - June 6th, 2017 [June 6th, 2017]
- Shoosmiths advises PD Neurotechnology on 1.34m (EUR) investment - Shoosmiths legal updates (press release) - June 7th, 2017 [June 7th, 2017]
- Comparing Accuray (ARAY) & Stryker (SYK) - The Cerbat Gem - June 9th, 2017 [June 9th, 2017]
- Welch Capital Partners Increased By $3.59 Million Its Eqt (EQT) Position, Stryker (SYK) Sellers Decreased By 3.59 ... - UtahHerald.com - June 10th, 2017 [June 10th, 2017]
- Head to Head Analysis: Accuray (ARAY) and Stryker Corporation (SYK) - Sports Perspectives - June 13th, 2017 [June 13th, 2017]
- Neurotechnology Announces MegaMatcher Accelerator Extreme ... - findBIOMETRICS - June 13th, 2017 [June 13th, 2017]
- Comparing Stryker Corporation (SYK) & Accuray (ARAY) - Markets Daily - June 14th, 2017 [June 14th, 2017]
- Neurotechnology Releases MegaMatcher Accelerator Extreme, the Fastest Biometric Engine in the World - PR Newswire (press release) - June 14th, 2017 [June 14th, 2017]
- Neurotech panel shares successes from first year - Cornell Chronicle - June 14th, 2017 [June 14th, 2017]
- Neurotechnology Researchers Win Kaggle Competition with Deep Neural Network Solution for The Nature ... - PR Newswire (press release) - June 14th, 2017 [June 14th, 2017]
- Neurotechnology Wins Fisheries-Focused Computer Vision Competition - findBIOMETRICS - June 14th, 2017 [June 14th, 2017]
- Helping or Hacking? Engineers, Ethicists Must Work Together on Brain-Computer Interface Technology - Government Technology - June 16th, 2017 [June 16th, 2017]
- Accuray (ARAY) versus Stryker Corporation (SYK) Head-To-Head Review - The Cerbat Gem - June 17th, 2017 [June 17th, 2017]
- The Funded: Justin Kan's latest startup gets backing from more than 100 investors - Silicon Valley Business Journal - June 17th, 2017 [June 17th, 2017]
- New SentiVeillance Server from Neurotechnology Adds Face Recognition and Analytics to Video Management Systems - PR Newswire (press release) - June 20th, 2017 [June 20th, 2017]
- Neurotechnology Announces SentiVeillance Server Facial Recognition Solution - findBIOMETRICS - June 20th, 2017 [June 20th, 2017]
- SentiVeillance Server - Face Recognition and Analytics to Video Management Systems - Officer.com (press release) (registration) (blog) - June 21st, 2017 [June 21st, 2017]
- Neurotechnology Announces MegaMatcher 10 - findBIOMETRICS - June 21st, 2017 [June 21st, 2017]
- Neurotechnology adds face recognition, tracking to video surveillance systems; researchers win competition - Biometric Update - June 22nd, 2017 [June 22nd, 2017]
- Neurotechnology makes a number of updates to the MegaMatcher product line - Biometric Update - June 23rd, 2017 [June 23rd, 2017]
- Neurotechnology Develops 3D Printing Method with Non-Contact Ultrasonic Manipulation Technology - 3DPrint.com - June 26th, 2017 [June 26th, 2017]
- Mind-blowing ultrasonic 'printer' uses lasers and high-frequency sound to assemble electronics - Digital Trends - June 29th, 2017 [June 29th, 2017]
- HIRREM Neurotechnology Better Than Placebo for Insomnia - Sleep Review - July 10th, 2017 [July 10th, 2017]
- DARPA invests further in neurotechnology - SD Times - SDTimes.com - July 14th, 2017 [July 14th, 2017]
- Infinitely Flexible 3D Printing with Ultrasonic Manipulation? - ENGINEERING.com - July 15th, 2017 [July 15th, 2017]
- Insider Activity Stryker Corporation (NYSE:SYK) - Highlight Press - July 16th, 2017 [July 16th, 2017]
- Comparing Uroplasty (UPI) and Stryker Corporation (NYSE:SYK) - The Cerbat Gem - July 17th, 2017 [July 17th, 2017]
- Biomimetic Underwater Robot Program - July 17th, 2017 [July 17th, 2017]
- Preserving the Right to Cognitive Liberty - Scientific American - July 18th, 2017 [July 18th, 2017]
- BRAIN center gathers to ponder future, direction - Arizona State University - July 20th, 2017 [July 20th, 2017]
- Stryker Expands Its Interventional Spine Segment - Market Realist - July 22nd, 2017 [July 22nd, 2017]
- Trivascular Technologies (TRIV) & Stryker Corporation (SYK) Critical Review - Stock Observer - July 26th, 2017 [July 26th, 2017]
- Arshya Vahabzadeh: Innovating at the Intersection of Brain ... - HuffPost - July 27th, 2017 [July 27th, 2017]
- fMRI and EEG May Be Able to Reveal Consciousness in Comatose Patients - Physical Therapy Products - July 29th, 2017 [July 29th, 2017]
- Stryker reports 6.1% Q2 growth, installs 26 Mako systems: 7 things to know - Becker's Orthopedic & Spine - July 29th, 2017 [July 29th, 2017]
- Tufts Hosts Engineering Conference - Tufts Now - July 29th, 2017 [July 29th, 2017]
- Stryker Corporation (NYSE:SYK) and Uroplasty (UPI) Financial Survey - Stock Observer - July 29th, 2017 [July 29th, 2017]
- Elon Musk speaks of being 'bipolar' on Twitter - Mashable - July 31st, 2017 [July 31st, 2017]
- Team Neurotechnology Innovations Translator - July 31st, 2017 [July 31st, 2017]
- Elon Musk opens up about the highs and lows of his life on Twitter - Firstpost - August 1st, 2017 [August 1st, 2017]
- Train your brain at Ky learning centre - Shepparton News - August 2nd, 2017 [August 2nd, 2017]
- Stryker Exceeded Analysts' Sales Estimates in 2Q17 - Market Realist - August 2nd, 2017 [August 2nd, 2017]
- $2.6 million to build versatile genetic toolkit for studying animal ... - Washington University in St. Louis Newsroom - August 3rd, 2017 [August 3rd, 2017]
- National Science Foundation $9M grant will fund neurotech research hub at Cornell - The Ithaca Voice - August 3rd, 2017 [August 3rd, 2017]
- NSF awards Cornell $9M grant for neurotech research hub - The Central New York Business Journal - August 4th, 2017 [August 4th, 2017]
- NSF issues awards to advance a national research infrastructure for neuroscience - National Science Foundation (press release) - August 4th, 2017 [August 4th, 2017]
- $9M Grant Will Create Neurotech Research Hub - Lansing Star - August 4th, 2017 [August 4th, 2017]
- NSF backs photonics-enabled neuroscience networks - Optics.org - August 9th, 2017 [August 9th, 2017]
- Washington University awarded $2.6 million for neurotechnology research - St. Louis Business Journal - August 9th, 2017 [August 9th, 2017]
- fMRI, EEG may detect consciousness in TBI patients - Medical Physics Web (subscription) - August 10th, 2017 [August 10th, 2017]
- Financial Analysis: Stryker Corporation (NYSE:SYK) vs. Uroplasty (UPI) - The Cerbat Gem - August 12th, 2017 [August 12th, 2017]
- In the Future, Humans Will Use Brain to Brain Communication and Download Their Memories If Elon Musk Has His Way - Newsweek - August 13th, 2017 [August 13th, 2017]
- How Elon Musk Plans to Turn Humans Into Robots - Yahoo News - August 14th, 2017 [August 14th, 2017]
- Critical Comparison: Stryker Corporation (SYK) versus Glaukos Corporation (GKOS) - TrueBlueTribune - August 21st, 2017 [August 21st, 2017]
- Early career scientists named Mong Fellows in Cornell Neurotech - Cornell Chronicle - August 21st, 2017 [August 21st, 2017]
- Could this back-pain device end need for opioids? - The Columbus Dispatch - August 21st, 2017 [August 21st, 2017]
- New technologies to diagnose and treat neurological diseases - Medical Xpress - August 22nd, 2017 [August 22nd, 2017]